PARADIGM BIOCAPITAL ADVISORS LP Viridian Therapeutics, Inc. Transaction History

PARADIGM BIOCAPITAL ADVISORS LP portfolio value:

$33.55M
portfolio value

PARADIGM BIOCAPITAL ADVISORS LP quarter portfolio value change:

+77.27%
quarter

Viridian Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +25.23% 329.64K shares 18.44M $20.51 1.63M
Q2 2022 share Increase +4.02% 50.51K shares -8.10M $11.57 1.30M
Q1 2022 share Increase +3.89% 47K shares -679K $18.49 1.25M
Q4 2021 share Increase 0.00% 1.20M shares 23.90M $20.3 1.20M